Shukra Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

10.95

3.91

1.57

1.57

1.57

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

46.69

21.38

14.78

14.03

13.85

Loan funds

Secured loans

0.50

1.31

0.25

-

-

Unsecured loans

2.66

3.77

3.13

9.77

8.05

Total

60.79

30.38

19.73

25.37

23.46

Uses of funds

Fixed assets

Gross block

41.33

41.22

35.08

17.69

33.40

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

21.38

20.99

17.50

-

16.02

Net block

19.94

20.23

17.58

17.69

17.38

Capital work-in-progress

1.66

1.66

1.66

1.66

1.66

Investments

-

-

0.20

0.19

0.05

Net current assets

Current assets, loans & advances

56.23

53.07

15.67

15.22

14.45

Less : current liabilities & provisions

17.04

44.59

15.39

9.39

10.08

Total net current assets

39.19

8.48

0.28

5.82

4.37

Miscellaneous expenses not written

-

-

-

-

-

Total

60.79

30.38

19.73

25.37

23.46

Notes:

Book value of unquoted investments

-

-

0.20

0.19

0.05

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

1.40

1.40

-

-

-

Number of equity sharesoutstanding (Lacs)

109.51

109.60

15.66

15.66

15.66